Drug intelligence / Profile preview

morphine + scopolamine

Development stage
Unknown
Modality
Small Molecules
Administration
Intramuscular, Subcutaneous
01

Overview

Morphine + scopolamine is a historical combination drug consisting of the opioid analgesic morphine and the anticholinergic agent scopolamine. This combination was primarily used in the early 20th century to induce "twilight sleep," a state characterized by analgesia (pain relief) and amnesia (loss of memory), most notably during childbirth. Morphine acts as a μ-opioid receptor agonist, providing strong pain relief, while scopolamine is a muscarinic acetylcholine receptor antagonist that impairs memory formation and reduces awareness of pain. The combined effect allowed patients to remain conscious but unable to recall painful procedures. Although once popular for obstetric anesthesia, this combination fell out of favor due to significant risks, including respiratory depression in both mother and infant[1][5][9].

Other names
twilight sleep mixture
02

Targets

mAChR (Muscarinic acetylcholine receptors)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on morphine + scopolamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + scopolamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call